Key result
Two different dosing strategies (up-titration vs pharmacologically-guided modification) were applied to manage the interaction between rifampicin and vitamin K antagonists to maintain therapeutic INR.
Why the study?
Rifampicin interacts with vitamin K antagonists, making it difficult to maintain the INR in therapeutic range in patients with staphylococcal prosthetic valve endocarditis and mechanical prostheses.
Case Report (n=2)
Managing the complex interaction between rifampicin and vitamin K antagonists in patients with prosthetic valve endocarditis requires individualized dosing strategies to maintain therapeutic anticoagulation.
Individualized dosing may maintain therapeutic INR during rifampicin-VKA interaction; leaves open optimal strategy in prosthetic valve endocarditis.
According to current European Society of Cardiology guidelines, for staphylococcal prosthetic valve endocarditis, rifampicin should be one of the drugs used. However, there is a concomitant need for vitamin K antagonists in patients with mechanical prostheses. It is widely known that rifampicin interacts with vitamin K antagonists (VKA), and this interaction makes it difficult to maintain the INR (international normalized ratio) value in the therapeutic range. We present two clinical cases of staphylococcal prosthetic valve endocarditis patients. Two different strategies for dealing with adverse drug interactions have been applied. In the first case, the dose of warfarin was up-titrated until the optimal INR value was obtained. In the second case, due to the history of labile INR values, a decision was made to modify the dosage of warfarin, taking into account pharmacological aspects of drug interactions.
No takes yet. Share an insight, caveat, or question.
Wełnicki et al. (2021) conducted a case report in Staphylococcal prosthetic valve endocarditis (n=2). Dosage adjustment strategies for vitamin K antagonists co-administered with rifampicin was evaluated on Optimal INR value. Two different dosing strategies (up-titration vs pharmacologically-guided modification) were applied to manage the interaction between rifampicin and vitamin K antagonists to maintain therapeutic INR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: